Elevance Health Reaffirm FY24 Adj. EPS Guidance To Be Greater Than $37.20 Vs. Cons. $37.28
Portfolio Pulse from Benzinga Newsdesk
Elevance Health has reaffirmed its FY24 adjusted EPS guidance to be greater than $37.20, slightly below the consensus estimate of $37.28.
June 12, 2024 | 10:18 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Elevance Health reaffirmed its FY24 adjusted EPS guidance to be greater than $37.20, which is slightly below the consensus estimate of $37.28. This may cause a minor negative reaction in the stock price due to the guidance being below expectations.
The reaffirmed guidance being slightly below the consensus estimate may lead to a minor negative reaction in the stock price as investors adjust their expectations.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100